Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, Academics, Students, and Life Sciences Industry Professionals:

Join members of the life sciences community in Lowell as the $200K Challenge finalists selected through a competitive process pitch their innovations to our panel of judges.

At stake: a share of a $200,000 purse of sponsor-provided, in-kind resources that can help take an innovation to the next level -- or even to market!

(Examples of in-kind resources include lab space, equipment, and legal/regulatory guidance)

We've seen past winners advance to larger funding rounds, commence clinical studies, and enter strategic partnerships with global life sciences companies. The $200K Challenge is the place to see what's up-and-coming in life sciences innovation.

TICKETS ARE FREE!

CLICK HERE TO REGISTER

Finalist Pitch-Off — Wednesday, March 22 @ 4pm ET

15 medical device startups will present their innovations to a panel of industry experts. At the pitch event, you can network with startups, judges, leaders from local biotech companies, industry partners, subject matter experts, and other life sciences entrepreneurs.

Food and drinks will be provided. Register now to secure your spot to network with colleagues and help shape the future of healthcare collaboratively.

Ample free parking (ticket validation) is available at the adjacent multi-story garage located at:

HCID Parking Facility, 350.4 Dutton Street, Lowell, MA 01852

Mary Ann Picard, M2D2 Director of Operations, commented on this year's $200K Challenge: “I'm thrilled to start another year with the $200K Challenge. Every year we meet new, passionate entrepreneurs that continue to inspire us and remind us why the innovation of medical and therapeutic devices is so important.”

2023 FINALISTS ANNOUNCED:

ArrowDx - Precision Diagnostics via Nanotechnology & Artificial Intelligence for NASH.

Aspivix - Novel Soft Cervical Stabilizer

Cosmos Pharmaceuticals - Remote therapeutic monitoring device to secure and monitor prescription medication

Dart Biosciences - Delivery solution - Focal Cortical Dysplasia type II (FCD II) as an initial target indication

EndoGlow - Fluorescent Guided Minimally Invasive Surgery

Fem Therapeutics - 3D customized gynaecological prosthetic for non-invasive treatment of pelvic health conditions

Genomic Expression - Novel RNA platform to detect disease, monitor health and design next gen cures

MIT (Spheric Bio) - Customized 3D implant for Left Atrial Appendage Closure

Matregenix - Platform Techology for Soft-tissue Repair

Meacor - Catheter-based device for minimally invasive heart valve treatment

Medicsen - SMARTPATCH new transdermal drug delivery method

National University of Singapore - Affordable hemostatic device

RevBio - 3D printed tetranite bone adhesive

UMass Lowell (Artemis BioSystems) - Accelerated Transposon Stable Producer Cell Line (AT-SPCL)

Vivifi Medical - Laparoscopic and robotic technology to reverse benign prostate hyperplasia

Fireside Chat Speakers Announced:

We're thrilled to share that Kenn Turner, President and CEO of Massachussets Life Sciences Center will be joining us as a Fireside Chat speaker. Those of you who attended the Barracuda Bowl in October saw first-hand the important questions, conversations and topics he highlights during these events.

Brian Johnson, President of MassMEDIC will join Kenn as a Fireside Chat speaker. They'll dig into an important and well-timed topic, "The Future of Medtech Leaders."